University of California, San Diego: Research to Revenue

University of California, San Diego

Summit Venture Studio

Research to Revenue Report

Summit Venture Studio (SVS) Opportunities

SVS has identified 111 commercialization opportunities from University of California, San Diego and scored them based on our proprietary metrics and rubrics.

The SVS model is to identify the top 1% of commercialization opportunities and start companies around them.

Please connect with SVS if you would like to engage with us in our startup and investment efforts.

Return on Research (ROR) Analysis

Commercialization Revenue per Research Dollar

Top Universities by Return on Research (ROR)

ROI Ratio: Commercialization Revenue ÷ Research Funding

University Innovation Analysis

Total Innovation Scores by Institution

Top Universities by Innovation Score

180+ High Innovation

150-179 Strong Innovation

130-149 Moderate Innovation

100-129 Emerging Innovation

130+ total score considered high innovation impact

SVS Innovation Index

Proprietary Assessment of University of California, San Diego's Innovation Ecosystem
Score out of 100. Benchmark: Top 50 U.S. research institutions.
A score of 90/100 can be read "doing better than 90% of schools benchmarked"

Innovation Visibility

60/100

Definition: Media mentions, publication count, and global research visibility metrics

Startup Momentum

9/100

Definition: Growth in patents, funding, and startup formation

Ecosystem Strength

56/100

Definition: Tech transfer infrastructure and support systems

Innovation Legacy

A Timeline of Groundbreaking Discoveries

Innovation Timeline

Founded

1960

First Nobel

1959

First Patent

1966

First IPO

1995

2022-2024

AI-powered diagnostics

2025

Today

Notable Commercialization Outcomes

Nobel Prizes

1980s

Gene Discovery

Discovered CFTR gene

1980s

Biotech Spinoff

Founded Genomic Health

1990s

Patent Milestone

Surpassed 1,000 patents

2000s

Startup Launch

Created multiple startups

2010s

Drug Approval

First FDA approved drug

2015

Competitive Benchmarking

University of California, San Diego vs. Peer Research Universities

University of California, San Diego vs Peers Comparison

Metric	University of California, San Diego (FY2023)	Peer Average	Elite Average
Annual R&D Expenditure	$1,705M	$855M	$1,675M
New Inventions Disclosed	3	200	400
Startups Formed	15	7	10
Visibility Index	13	12	23
Licensing Revenue	$45M	$17M	$46M

Note: Peer Average = Median value among U.S. R1 research universities. Elite Average = Top 10 ranked U.S. research universities.

Emerging Opportunities

1. AI-Driven Drug Discovery Accelerates Therapeutic Development

UCSD’s AI platform streamlines drug discovery, reducing time and cost, addressing urgent global healthcare needs, and enabling scalable pharmaceutical innovation.

2. Next-Gen Quantum Computing Hardware for Industry Applications

UCSD pioneers scalable quantum devices, offering competitive advantage in computing power essential for cryptography, materials science, and complex problem-solving markets.

3. Bioengineered Tissue Implants Revolutionize Regenerative Medicine

UCSD’s biofabrication technologies create customizable, functional tissue implants, addressing organ shortage crises and enabling scalable, personalized regenerative therapies.

4. Sustainable Energy Storage Solutions Transform Power Grids

UCSD develops advanced battery tech with higher capacity and longevity, tackling renewable energy intermittency, supporting scalable, reliable clean energy infrastructure.

5. Advanced Robotics for Precision Surgery Enhances Patient Outcomes

UCSD’s robotic systems improve surgical accuracy and reduce recovery times, meeting growing demand for minimally invasive procedures with scalable healthcare applications.

6. Novel Microbiome Therapeutics Target Chronic Diseases

UCSD’s microbiome research leads to scalable therapies addressing gut-related illnesses, offering competitive edge in personalized medicine and expanding global healthcare markets.